MetLife Investment Management’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.94M Sell
27,528
-681
-2% -$116K 0.03% 619
2025
Q4
$3.99M Sell
28,209
-984
-3% -$112K 0.02% 728
2025
Q3
$2.37M Buy
+29,193
New +$2.25M 0.01% 1009
2025
Q2
Sell
-30,528
Closed -$2.2M 2756
2025
Q1
$2.2M Sell
30,528
-575
-2% -$46.8K 0.01% 991
2024
Q4
$2.68M Buy
31,103
+548
+2% +$54.6K 0.01% 896
2024
Q3
$2.89M Sell
30,555
-785
-3% -$69.7K 0.02% 821
2024
Q2
$2.99M Buy
31,340
+3,870
+14% +$460K 0.02% 777
2024
Q1
$3.62M Sell
27,470
-1,011
-4% -$124K 0.02% 673
2023
Q4
$4.11M Sell
28,481
-537
-2% -$73.7K 0.03% 589
2023
Q3
$4.93M Sell
29,018
-759
-3% -$151K 0.04% 409
2023
Q2
$6.64M Sell
29,777
-2,857
-9% -$584K 0.05% 328
2023
Q1
$7.21M Sell
32,634
-53
-0.2% -$13.1K 0.05% 296
2022
Q4
$7.09M Sell
32,687
-599
-2% -$160K 0.05% 295
2022
Q3
$8.8M Sell
33,286
-432
-1% -$110K 0.07% 218
2022
Q2
$7.05M Buy
33,718
+2,202
+7% +$491K 0.05% 278
2022
Q1
$6.97M Buy
31,516
+5,967
+23% +$1.26M 0.05% 350
2021
Q4
$5.97M Sell
25,549
-486
-2% -$120K 0.05% 327
2021
Q3
$5.7M Sell
26,035
-647
-2% -$138K 0.05% 317
2021
Q2
$4.49M Sell
26,682
-733
-3% -$118K 0.04% 444
2021
Q1
$4.01M Buy
27,415
+1,907
+7% +$306K 0.04% 505
2020
Q4
$3.76M Sell
25,508
-1,107
-4% -$131K 0.04% 502
2020
Q3
$2.38M Sell
26,615
-958
-3% -$84.9K 0.03% 645
2020
Q2
$2.13M Buy
27,573
+242
+0.9% +$16.4K 0.02% 689
2020
Q1
$1.54M Sell
27,331
-836
-3% -$64.1K 0.02% 710
2019
Q4
$2.06M Sell
28,167
-675
-2% -$45.1K 0.02% 800
2019
Q3
$2.01M Sell
28,842
-363
-1% -$24.7K 0.02% 790
2019
Q2
$2.06M Sell
29,205
-856
-3% -$63.2K 0.02% 801
2019
Q1
$2.46M Sell
30,061
-310
-1% -$25.3K 0.03% 724
2018
Q4
$2.34M Sell
30,371
-1,177
-4% -$111K 0.03% 684
2018
Q3
$3.15M Sell
31,548
-1,058
-3% -$102K 0.03% 639
2018
Q2
$3.08M Sell
32,606
-689
-2% -$66.1K 0.04% 592
2018
Q1
$3.09M Sell
33,295
-893
-3% -$98.4K 0.04% 596
2017
Q4
$4.37M Buy
+34,188
New +$4.64M 0.05% 409

Other funds holding ALB

MetLife Investment Management's ALB Position: Q1 2026 in Review

MetLife Investment Management reduced its Albemarle (ALB) stake by 2.4% in Q1 2026, selling an estimated $116K and leaving 27,528 shares worth $4.94M. The position accounts for 0.03% of the portfolio, ranked #619.

MetLife Investment Management first reported a position in ALB in Q4 2017 and has held it in 33 quarters since. The position peaked at $8.8M in Q3 2022. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

  • MetLife Investment Management held 27,528 shares of Albemarle worth $4.94M as of Q1 2026.
  • MetLife Investment Management sold 681 Albemarle shares in Q1 2026, an estimated $116K.
  • Albemarle made up 0.03% of MetLife Investment Management's portfolio in Q1 2026, its #619 holding.
  • MetLife Investment Management first reported a position in Albemarle in Q4 2017 and has held it in 33 quarters since.
  • MetLife Investment Management's Albemarle position peaked at $8.8M in Q3 2022.
  • 982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.